Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
2
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
3
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
4
Real-World Experience With Aflibercept 8 mg in Retinal Vascular Diseases
5

